Abbott receives FDA approval for new CardioMEMS HF system capabilities
ABT•Abbott received FDA approval for new CardioMEMS HF system capabilities intended to help patients engage in the care of their heart condition. The CardioGuide HF app and Dynamic Treatment Plan are expected to be available later this year.
1. FDA approval
Abbott said it received FDA approval for new capabilities in its CardioMEMS HF system to help patients engage in the care of their heart condition. The CardioGuide HF app and Dynamic Treatment Plan are expected to be available later this year.
